Proteros Biostructures GmbH

Industry

  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Drug Discovery Technologies
      • Molecular Diversity
  • Pharmaceuticals
See more in Biomedtracker

Latest on Proteros Biostructures GmbH

Scrip

Deal Watch: OrsoBio Reveals Its Metabolic Health Focus With Four Licensing Pacts

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. OrsoBio Splurges With Four Concurrent L

Scrip

Deal Watch: Innoviva To Buy The Rest Of Entasis For Enterprise Value Of $113m

 
• By Joseph Haas and Ayisha Sharma

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Innoviva Acquisition Of Entasis Leaves

Scrip

Deal Watch: AbbVie To Try Caraway’s Lysosomal Function Approach To Parkinson’s

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie, Caraway Research Targets TMEM17

Scrip

More Positive Data As Decision Day Looms For AstraZeneca Lupus Drug

 
• By Kevin Grogan

With anifrolumab under review by regulatory authorities in the US, EU and Japan, AstraZeneca PLC has presented more positive data on the therapy which could become the first treatment approved for s